A 59-Year-Old Man With Extensive-Stage Small Cell Lung Cancer

Thought leader in thoracic oncology, Hossein Borghaei, DO, reviews the case of a 59-year-old man with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.